Cargando…

2387. Learning the Influence of Individual Clostridioides difficile Infections

BACKGROUND: Healthcare-associated Clostridioides difficile infection (C diff infection, or CDI) imposes a substantial burden on the healthcare system. The impact of an individual C diff infection on onward transmission is not well understood. We developed a model of incident infections using self-ex...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mu, Emily, Makar, Maggie, West, Lauren R, Guttag, John, Rosenberg, David C, Shenoy, Erica S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810728/ http://dx.doi.org/10.1093/ofid/ofz360.2065

Ejemplares similares

400. Rehospitalization of Patients for Recurrent Clostridioides difficile Infection
por: Drwiega, Emily, et al.
Publicado: (2022)

2387. Selecting Clostridium difficile Infection (CDI) Outcome Measures Relevant to Public Health Concerns: Experience From a Ridinilazole (RDZ) Phase 2 Trial
por: Vickers, Richard, et al.
Publicado: (2018)

471. Prevalence and Characteristics of Clostridioides difficile Infection in Bangladesh
por: Sofjan, Amelia K, et al.
Publicado: (2018)

290. Prediction of Severe Clostridioides difficile Infection Using Isolate Genomic Variation Influenced by Patient Comorbidity Score
por: Maggioncalda, Emily C, et al.
Publicado: (2023)

2413. Assessment of compliance with Clostridioides difficile prophylaxis guideline and its efficacy on secondary prophylaxis and reducing hospital-onset Clostridioides difficile infections.
por: Vyas, Nikunj M, et al.
Publicado: (2019)

2235. Fecal Biomarkers for Clostridioides difficile Infection in Cancer Patients
por: Olvera, Adilene, et al.
Publicado: (2019)

381. Antibiotic Spectrum Index and Risk of Clostridioides difficile Infection
por: Ray, Michael J, et al.
Publicado: (2022)

2404. Molecular Epidemiology of Clostridioides difficile in the United States, 2017
por: Paulick, Ashley, et al.
Publicado: (2019)

2389. Assessing the Time Course of Proton Pump Inhibitor Use and Clostridioides difficile Infection
por: Panagos, Katherine, et al.
Publicado: (2019)

PROJECT ADMINISTRATION AGREEMENT KN 2387 FP
por: THE EUROPEAN ORGANIZATION FOR NUCLEAR RESEARCH, CERN, et al.
Publicado: (2014)

2397. Effects of antimicrobial surgical prophylaxis on rates of Clostridioides difficile infection
por: Hayes, Sarah K, et al.
Publicado: (2019)

709. Post-Clostridioides difficile Infection Neuroinflammatory Response in an Animal Model
por: Yang, Suemin E, et al.
Publicado: (2023)

674. Host and Pathogen Risk Factors for Fulminant Clostridioides difficile Infection
por: Chua, Hubert C, et al.
Publicado: (2023)

2351. Rate and Consequences of Missed Clostridioides (Clostridium) difficile Infection Diagnosis from Non-disclosure of Clostridioides difficile Multiplex PCR Results. Two-Hospital Experience
por: Zacharioudakis, Ioannis, et al.
Publicado: (2019)

2387. Assessment of COVID-19 primary series vaccination and factors associated with early and late uptake among Servicemembers in the Military Health System
por: Stewart, Laveta, et al.
Publicado: (2023)

783. Clostridioides difficile Infection among Maintenance Hemodialysis Patients
por: Radhakrishnan, Parvathi, et al.
Publicado: (2020)

2398. Effect of Eosinopenia and Binary Toxin on Clostridioides difficile Infection Clinical Outcomes
por: Carlson, Travis J, et al.
Publicado: (2019)

2361. Evaluation of a 2-Step Testing Algorithm for Clostridioides difficile Infection
por: Zuccaro, Patricia, et al.
Publicado: (2019)

2368. Molecular Epidemiology of Clostridioides difficile Infections in Pediatric Oncology and Transplant Patients
por: Barbar, Ruba, et al.
Publicado: (2019)

390. Eravacycline combination therapy for severe, recurrent, or fulminant Clostridioides difficile infection
por: Morrison, Austin R, et al.
Publicado: (2022)

2692. Epidemiology and Risk Factors for Clostridioides difficile Infection after Pancreas Transplantation
por: Akhtar, Haris, et al.
Publicado: (2023)

1203. Impact of Antimicrobial Stewardship Interventions on Hospital-Onset Clostridioides difficile Infections
por: Kwon, Taesung, et al.
Publicado: (2023)

679. Retrospective Analysis of Vancomycin and Fidaxomicin for the Treatment of Recurrent Clostridioides difficile Infection
por: Fabian, Amy, et al.
Publicado: (2023)

2347. Impact of Multidisciplinary Review of Clostridioides difficile Testing
por: Foreman, Jena, et al.
Publicado: (2019)

Diagnostic Methods of Clostridioides difficile Infection and Clostridioides difficile Ribotypes in Studied Sample
por: Novakova, Elena, et al.
Publicado: (2021)

2433. Oral Vancomycin Plus Intravenous Metronidazole for Severe Clostridioides difficile Infection in Critically Ill Patients
por: Vega, Ana D, et al.
Publicado: (2019)

71. Diagnostic Stewardship of Clostridioides difficile Testing
por: Qamar, Zahra, et al.
Publicado: (2021)

801. Patients with Clostridioides difficile Infection Following Dental Antibiotic Prescription
por: Wilson, Geneva M, et al.
Publicado: (2020)

752. Costs Attributable to Clostridioides difficile Infection in the Presence of Differential Mortality
por: Sahrmann, John, et al.
Publicado: (2021)

Extraintestinal Clostridioides difficile infection
por: Hai, Zhao, et al.
Publicado: (2020)

2376. Incidence of Clostridioides difficile Infection Among United States Medicare Advantage Enrollees
por: Heinrich, Kirstin, et al.
Publicado: (2019)

2383. Epidemiological and Clinical Features of Clostridioides difficile Infections in Pediatric Oncology and Transplant Patients
por: Barbar, Ruba, et al.
Publicado: (2019)

2435. The Impact of Treatment Strategy and Toxin Status on Outcomes of Patients with Clostridioides difficile Infections
por: Friedman, Daniel, et al.
Publicado: (2019)

2371. A Multicenter Cohort Study of the Natural History of Clostridioides difficile Colonization and Infection
por: Curry, Scott R, et al.
Publicado: (2019)

2430. Comorbidity and Severity of Illness Risk Adjustment for Hospital-Onset Clostridioides difficile Infection
por: Cabral, Stephanie, et al.
Publicado: (2019)

382. Are errors of omission falsely inflating hospital-onset Clostridioides difficile infection numbers?
por: Parada, Jorge Paiva, et al.
Publicado: (2022)

692. The Role of Fidaxomicin for the Treatment of Clostridioides Difficile Infection in the Pediatric Population in the United States
por: Lee, Yuman, et al.
Publicado: (2023)

672. Impact of Multistep Testing Algorithm on Hospital Acquired Clostridioides difficile Infection Rates
por: Betancourth, Adriana C, et al.
Publicado: (2023)

698. Prevalence of Clostridioides difficile Infection in Patients with Isolated Glutamate Dehydrogenase (GDH) Positive
por: Pharnusopon, Tanadhol, et al.
Publicado: (2023)

529. Overdiagnosis of Clostridioides difficile with a Multiplex PCR Panel
por: Arora, Vaneet, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_c758ajarvfbr2p4d0v6fgeppar